Again, the majority of patients enrolled were systemic ALCL (n = 316, ALK-negative: n = 218, ALK-positive: n = 98); however, PTCL-NOS (n = 72) and AITL (n = 54) were represented. This evidence concerns the gene ALK and anaplastic large cell lymphoma.